Jaber S Alqahtani,1,2 Yousef S Aldabayan,3 Abdulelah M Aldhahir,4 Ahmad M Al Rajeh,3 Swapna Mandal,1,5,* John R Hurst1,5,* 1UCL Respiratory, University College London, London, UK; 2Department of Respiratory Care, Prince Sultan Military College of Health Sciences, Dammam, Saudi Arabia; 3Respiratory Care Department, College of Applied Medical Sciences, King Faisal University, Al-Hasa, Saudi Arabia; 4Respiratory Care Department, Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia; 5Respiratory Medicine, Royal Free London NHS Foundation Trust, London, UK*These authors contributed equally to this workCorrespondence: Jaber S AlqahtaniUCL Respiratory, University College London, Rowland Hill Street, London, NW3 2P...
BackgroundSignificant numbers of chronic obstructive respiratory disease patients are readmitted for...
BackgroundReadmissions after exacerbations of chronic obstructive pulmonary disease (COPD) are penal...
Marjan Kerkhof,1 Daryl Freeman,2 Rupert Jones,3 Alison Chisholm,4 David B Price1,5 On behalf of the...
Background: Readmission following COPD exacerbation is a common and challenging clinical problem. Ne...
INTRODUCTION AND OBJECTIVES:The aim of this study was to evaluate the predictive ability of multiple...
Chronic obstructive pulmonary disease (COPD) is a highly prevalent disease worldwide; acute exacerba...
Background: Readmission rates following hospitalisation for COPD exacerbations are unacceptably high...
Background: Readmission after hospital discharge is common in patients with acute exacerbations (AE)...
Introduction: People living with chronic obstructive pulmonary disease (COPD) are susceptible to acu...
Background: Exacerbations of chronic obstructive pulmonary disease (COPD) are a leading cause of adm...
COPD is currently one of the top 3 causes of death in the world with high morbidity and mortality. V...
Tzy-Chyi Yu,1 Huanxue Zhou,2 Kangho Suh,1 Stephen Arcona1 1Novartis Pharmaceuticals Corporation, Eas...
Background and Objective Twenty per cent of chronic obstructive pulmonary disease (COPD) patients ar...
Frequent COPD exacerbations have a large impact on morbidity, mortality and health-care expenditures...
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of unplanned readmission...
BackgroundSignificant numbers of chronic obstructive respiratory disease patients are readmitted for...
BackgroundReadmissions after exacerbations of chronic obstructive pulmonary disease (COPD) are penal...
Marjan Kerkhof,1 Daryl Freeman,2 Rupert Jones,3 Alison Chisholm,4 David B Price1,5 On behalf of the...
Background: Readmission following COPD exacerbation is a common and challenging clinical problem. Ne...
INTRODUCTION AND OBJECTIVES:The aim of this study was to evaluate the predictive ability of multiple...
Chronic obstructive pulmonary disease (COPD) is a highly prevalent disease worldwide; acute exacerba...
Background: Readmission rates following hospitalisation for COPD exacerbations are unacceptably high...
Background: Readmission after hospital discharge is common in patients with acute exacerbations (AE)...
Introduction: People living with chronic obstructive pulmonary disease (COPD) are susceptible to acu...
Background: Exacerbations of chronic obstructive pulmonary disease (COPD) are a leading cause of adm...
COPD is currently one of the top 3 causes of death in the world with high morbidity and mortality. V...
Tzy-Chyi Yu,1 Huanxue Zhou,2 Kangho Suh,1 Stephen Arcona1 1Novartis Pharmaceuticals Corporation, Eas...
Background and Objective Twenty per cent of chronic obstructive pulmonary disease (COPD) patients ar...
Frequent COPD exacerbations have a large impact on morbidity, mortality and health-care expenditures...
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of unplanned readmission...
BackgroundSignificant numbers of chronic obstructive respiratory disease patients are readmitted for...
BackgroundReadmissions after exacerbations of chronic obstructive pulmonary disease (COPD) are penal...
Marjan Kerkhof,1 Daryl Freeman,2 Rupert Jones,3 Alison Chisholm,4 David B Price1,5 On behalf of the...